Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

34.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.0K
Epigenetic Regulation01:37

Epigenetic Regulation

3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K
Histone Modification02:32

Histone Modification

4.6K
No description available
4.6K
Histone Modification02:32

Histone Modification

16.4K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.4K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Process Development in the Pharmaceutical Industry in Europe-Insights and Perspectives from Industry Scientists.

Angewandte Chemie (International ed. in English)·2025
Same author

Enantioselective Protein Affinity Selection Mass Spectrometry (E-ASMS).

bioRxiv : the preprint server for biology·2025
Same author

Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling.

SLAS discovery : advancing life sciences R & D·2025
Same author

DARPin-induced reactivation of p53 in HPV-positive cells.

Nature structural & molecular biology·2025
Same author

Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitro.

Cell death & disease·2025
Same author

Molecular basis of JAK kinase regulation guiding therapeutic approaches: Evaluating the JAK3 pseudokinase domain as a drug target.

Advances in biological regulation·2025
Same journal

Synthesis and Biological Evaluation of C6-O-Glycosylated α-Mangostin Derivatives Against Methicillin-Resistant Staphylococcus aureus With Enhanced Bacterial Membrane Selectivity.

ChemMedChem·2026
Same journal

Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes.

ChemMedChem·2026
Same journal

Discovery of Ligands for the TNFR1 Extracellular Domain Using Fragment-Based Drug Discovery.

ChemMedChem·2026
Same journal

An Ugi-Joullié Platform for Medicinally Relevant 1,4-Dihydrobenzothiazines.

ChemMedChem·2026
Same journal

Metal-Drug Complexes as Long-Release Application for Antimalarial PfFNT-Inhibitors.

ChemMedChem·2026
Same journal

Speciation Studies of Monosubstituted Pt, Mo, and W Decavanadates in Culture Media and In Vitro Activity Against Trypanosoma cruzi.

ChemMedChem·2026
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.5K

Small-molecule modulators for epigenetics targets.

Stefan Knapp1, Hilmar Weinmann

  • 1Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building and Target Discovery Institute, Roosevelt Drive, Headington, Oxford, OX3 7FZ (UK).

Chemmedchem
|October 16, 2013
PubMed
Summary
This summary is machine-generated.

Influencing epigenetic mechanisms offers potential for treating cancer, inflammation, and metabolic disorders. Experts convened to discuss advancements and future directions in this key area of medical research.

Keywords:
bromodomainscancerchemical probesepigenetic targetshistone methyltransferaseinhibitors

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

2.0K
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

7.0K

Related Experiment Videos

Last Updated: Feb 19, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.5K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

2.0K
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

7.0K

Area of Science:

  • Epigenetics and Molecular Biology
  • Translational Medicine

Background:

  • Epigenetic mechanisms are increasingly recognized for their role in various diseases.
  • Understanding these mechanisms is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To convene leading experts in epigenetics.
  • To discuss recent advancements and future trends in epigenetic research.
  • To explore the therapeutic potential of influencing epigenetic mechanisms.

Main Methods:

  • Expert-led discussions and presentations.
  • Sharing of recent success stories in epigenetic research.
  • Collaborative brainstorming on future trends.

Main Results:

  • Highlighted the significant relevance of influencing epigenetic mechanisms for future therapies.
  • Identified key disease areas including cancer, inflammation, and metabolic disorders.
  • Facilitated knowledge exchange among top researchers.

Conclusions:

  • Epigenetic modifications represent a promising frontier for disease treatment.
  • Continued research and collaboration are essential to translate epigenetic findings into clinical applications.